BIPHOZYL sol 3.05 g 2x5000 ml

7680660740015 CH-66074 B05ZB 05.04.0.
BIPHOZYL sol 3.05 g 2x5000 ml
BIPHOZYL sol 3.05 g 2x5000 ml
BIPHOZYL sol 3.05 g 2x5000 ml
1 / 3
google

Details

GTIN
7680660740015
Pharmacode
-
Product number
6607401
CPT
-
Packaging group
2 x 5000
Unit
ml
Composition
I) Kleine Kammer A: magnesii chloridum hexahydricum 3.05 g, acidum hydrochloridum dilutum, aqua ad iniectabile, aqua q.s. ad solutionem pro 1000 ml. II) Grosse Kammer B: natrii chloridum 7.01 g, natrii hydrogenocarbonas 2.12 g, kalii chloridum 314 mg, dinatrii phosphas dihydricus 187 mg, carbonei dioxidum, aqua ad iniectabile, aqua q.s. ad solutionem pro 1000 ml. I) et II) corresp.: mineralia: natrium 140 mmol/l, kalium 4 mmol/l, magnesium 0.75 mmol/l, chloridum 122 mmol/l, hydrogenophosphas 1 mmol/l, hydrogenocarbonas 22 mmol/l, in solutione recenter reconstituta.

Articles (1)

Biphozyl, Lösung für Hämodialyse und Hämofiltration
Lösung
2 x 5000
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/03/2025
Professional SmPC
Français
13/03/2025
Professional SmPC
Italien
13/03/2025

Detailed composition

Substance Quantity Type Category
natrii chloridum
7.01 G Substance Wirkstoff (Principe actif)
magnesii chloridum hexahydricum
3.05 G Substance Wirkstoff (Principe actif)
natrium
140.0 MMOLL Substance Wirkstoff (Principe actif)
natrii hydrogenocarbonas
2.12 G Substance Wirkstoff (Principe actif)
acidum hydrochloridum dilutum
- Substance HNIDK
kalii chloridum
314.0 MG Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
kalium
4.0 MMOLL Substance Wirkstoff (Principe actif)
dinatrii phosphas dihydricus
187.0 MG Substance Wirkstoff (Principe actif)
magnesium
0.75 MMOLL Substance Wirkstoff (Principe actif)
carbonei dioxidum
- Substance HNIDK
chloridum
122.0 MMOLL Substance Wirkstoff (Principe actif)
hydrogenophosphas
1.0 MMOLL Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
hydrogenocarbonas
22.0 MMOLL Substance Wirkstoff (Principe actif)

Authorization holder

Vantive GmbH

8152 Opfikon

Authorization information

Swissmedic authorization number
66074
Drug name
Biphozyl, Lösung für Hämodialyse und Hämofiltration
Galenic form
HÄMHH
ATC Code
B05ZB
Authorization status
Z
Dispensation category
B
First authorization
06/04/2017
Authorization expiration date
31/12/9999
IT number
05.04.0.
Domain
Human medicine
Field of application
Hämofiltration

Packaging details

Description (FR)
BIPHOZYL sol 3.05 g 2x5000 ml
Description (DE)
BIPHOZYL Lös 3.05 g 2x5000 ml
Market launch
01/03/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data